patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug
YUFLYMA
Marketedupdated 2mo agoby Celltrion Inc
Approvedcommunity read0 votes
all catalysts(14)
approval · 14
May 23, 2023
approval
YUFLYMA (ADALIMUMAB-AATY) — FDA approval
YUFLYMA
→
Sep 6, 2023
approval
YUFLYMA (ADALIMUMAB-AATY) — FDA approval
YUFLYMA
→
Sep 21, 2023
approval
YUFLYMA (ADALIMUMAB-AATY) — FDA approval
YUFLYMA
→
Oct 2, 2023
approval
YUFLYMA (ADALIMUMAB-AATY) — FDA approval
YUFLYMA
→
Nov 30, 2023
approval
YUFLYMA (ADALIMUMAB-AATY) — FDA approval
YUFLYMA
→
Dec 22, 2023
approval
YUFLYMA (ADALIMUMAB-AATY) — FDA approval
YUFLYMA
→
Dec 22, 2023
approval
YUFLYMA (ADALIMUMAB-AATY) — FDA approval
YUFLYMA
→
Dec 22, 2023
approval
YUFLYMA (ADALIMUMAB-AATY) — FDA approval
YUFLYMA
→
Aug 16, 2024
approval
YUFLYMA (ADALIMUMAB-AATY) — FDA approval
YUFLYMA
→
Dec 23, 2024
approval
YUFLYMA (ADALIMUMAB-AATY) — FDA approval
YUFLYMA
→
Apr 7, 2025
approval
YUFLYMA (ADALIMUMAB-AATY) — FDA approval
YUFLYMA
→
May 21, 2025
approval
YUFLYMA (ADALIMUMAB-AATY) — FDA approval
YUFLYMA
→
May 21, 2025
approval
YUFLYMA (ADALIMUMAB-AATY) — FDA approval
YUFLYMA
→
Oct 16, 2025
approval
YUFLYMA (ADALIMUMAB-AATY) — FDA approval
YUFLYMA
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that